Drug-eluting stents and the future of coronary artery bypass surgery: Facts and fiction

Annals of Thoracic Surgery

Volumn 81, Issue 3, 2006, Pages 1162-1171

  Raja, Shahzad G ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HYPOCHOLESTEROLEMIC AGENT; PACLITAXEL; RAPAMYCIN; TICLOPIDINE;

ANGIOCARDIOGRAPHY; BREAST TUMOR; CORONARY ARTERY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; LONG TERM CARE; MEDICAL ASSESSMENT; MEDICAL PRACTICE; MEDICAL TECHNOLOGY; OVARY TUMOR; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT;

CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; CORONARY DISEASE; EQUIPMENT DESIGN; HUMANS; MULTICENTER STUDIES; RANDOMIZED CONTROLLED TRIALS; STENTS; TREATMENT OUTCOME;

EID: 32844471142     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.08.002     Document Type: Review

References (93)

1. G.W. Vetrovec Don't blame the stents J Am Coll Cardiol 43 2004 1355 1357
2. SoS Investigators Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial) a randomised controlled trial Lancet 360 2002 965 970
3. D.A. Morrison, G. Sethi, J. Sacks Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, the Angina With Extremely Serious Operative Mortality Evaluation (AWESOME) J Am Coll Cardiol 38 2001 143 149
4. S.J. Pocock, R.A. Henderson, A.F. Rickards Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery Lancet 346 1995 1184 1189
5. S.N. Hoffman, J.A. TenBrook, M.P. Wolf, S.G. Pauker, D.N. Salem, J.B. Wong A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty one- to eight-year outcomes J Am Coll Cardiol 41 2003 1293 1304
6. S. Yusuf, D. Zucker, P. Peduzzi Effect of coronary artery bypass graft surgery on survival overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 1994 563 570
7. G.G. Biondi-Zoccai, A. Abbate, P. Agostoni Stenting versus surgical bypass grafting for coronary artery disease systematic overview and meta-analysis of randomized trials Ital Heart J 4 2003 271 280
8. P.W. Serruys, F. Unger, J.E. Sousa Arterial Revascularization Therapies Study Group Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease N Engl J Med 344 2001 1117 1124
9. W.W. Chu, R. Waksman Contemporary use of drug-eluting stents Curr Treat Options Cardiovasc Med 7 2005 35 46
10. T.M. Schiele, F. Krotz, V. Klauss Vascular restenosis-striving for therapy Expert Opin Pharmacother 5 2004 2221 2232
11. V. Rajagopal, S.G. Rockson Coronary restenosis a review of mechanisms and management Am J Med 115 2003 547 553
12. V. Bhatia, R. Bhatia, S. Dhindsa Drug-eluting intra-coronary stents have we got the magic bullet? J Postgrad Med 49 2003 291 296
13. M.A. Costa, M. Sabate, W.J. van der Giessen Late coronary occlusion after intracoronary brachytherapy Circulation 100 1999 789 792
14. D.S. Baim New devices for percutaneous coronary intervention are rapidly making bypass surgery obsolete Curr Opin Cardiol 19 2004 593 597
15. P.S. Teirstein A chicken in every pot and a drug-eluting stent in every lesion Circulation 109 2004 1906 1910
16. W.E. Cohn Surgical coronary revascularization remains relevant in the era of stents Curr Opin Cardiol 19 2004 589 592
17. S.G. Raja Drug-eluting stents is it the beginning of the end for coronary artery bypass surgery? Chin Med J (Engl) 117 2004 1377 1387
18. S.G. Raja Drug-eluting stents the myth, the reality CML Interv Cardiol Monit 12 2005 1 7
19. J.E. Sousa, P.W. Serruys, M.A. Costa New frontiers in cardiology: drug-eluting stents: part I Circulation 107 2003 2274 2279
20. J.E. Sousa, P.W. Serruys, M.A. Costa New frontiers in cardiology: drug-eluting stents: part II Circulation 107 2003 2383 2389
21. J.A. Stanik-Hutt Drug-coated stents preventing restenosis in coronary artery disease J Cardiovasc Nurs 19 2004 404 408
22. M.C. Morice, P.W. Serruys, J.E. Sousa Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
23. J.W. Moses, M.B. Leon, J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
24. J. Schofer, M. Schluter, A.H. Gershlick Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
25. E. Schampaert, E.A. Cohen, M. Schluter The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) J Am Coll Cardiol 43 2004 1110 1115
26. D. Ardissino, C. Cavallini, E. Bramucci Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries a randomized trial JAMA 292 2004 2727 2734
27. E. Grube, S. Silber, K.E. Hauptmann TAXUS I six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation 107 2003 38 42
28. A. Colombo, J. Drzewiecki, A. Banning Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions Circulation 108 2003 788 794
29. G.W. Stone, S.G. Ellis, D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
30. A. Gershlick, I. De Scheerder, B. Chevalier Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial Circulation 109 2004 487 493
31. M.K. Hong, G.S. Mintz, C.W. Lee Paclitaxel coating reduces in-stent intimal hyperplasia in human coronary arteries a serial volumetric intravascular ultrasound analysis from the Asian Paclitaxel-Eluting Stent Clinical Trial (ASPECT) Circulation 107 2003 517 520
32. A.J. Lansky, R.A. Costa, G.S. Mintz Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions angiographic follow-up of the DELIVER clinical trial Circulation 109 2004 1948 1954
33. J. Fajadet, M.C. Morice, C. Bode Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents three-year results of the RAVEL trial Circulation 111 2005 1040 1044
34. J.J. Goy, J.C. Stauffer, M. Siegenthaler, A. Benoit, C. Seydoux A prospective randomized comparison between paclitaxel and sirolimus stents in the real world of interventional cardiology the TAXi trial J Am Coll Cardiol 45 2005 308 311
35. M.M. Kittleson, D.M. Needham, S.J. Kim, B.K. Ravindran, S.S. Solomon, E. Guallar The efficacy of sirolimus- and paclitaxel-eluting stents a meta-analysis of randomized controlled trials Can J Cardiol 21 2005 581 587
36. C. Indolfi, M. Pavia, I.F. Angelillo Drug-eluting stents versus bare metal stents in percutaneous coronary interventions (a meta-analysis) Am J Cardiol 95 2005 1146 1152
37. D.G. Katritsis, E. Karvouni, J.P. Ioannidis Meta-analysis comparing drug-eluting stents with bare metal stents Am J Cardiol 95 2005 640 643
38. N. Shafiq, S. Malhotra, P. Pandhi, A. Grover, A. Uboweja A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease Br J Clin Pharmacol 59 2005 94 101
39. G.G. Biondi-Zoccai, P. Agostoni, A. Abbate Adjusted indirect comparison of intracoronary drug-eluting stents evidence from a metaanalysis of randomized bare-metal-stent-controlled trials Int J Cardiol 100 2005 119 123
40. M.N. Babapulle, L. Joseph, P. Belisle, J.M. Brophy, M.J. Eisenberg A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents Lancet 364 2004 583 591
41. A.J. Scheen, F. Warzee, V.M. Legrand Drug-eluting stents meta-analysis in diabetic patients Eur Heart J 25 2004 2167 2168
42. G. Oliva, M. Espallargues, J.M. Pons Antiproliferative drug-eluting stents systematic review of the benefits and estimate of economic impact Rev Esp Cardiol 57 2004 617 628
43. R. Hill, A. Bagust, A. Bakhai Coronary artery stents a rapid systematic review and economic evaluation Health Technol Assess 8 2004 1 242
44. R.A. Hill, Y. Dundar, A. Bakhai, R. Dickson, T. Walley Drug-eluting stents an early systematic review to inform policy Eur Heart J 25 2004 902 919
45. P.A. Lemos, P.W. Serruys, R.T. van Domburg Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world" the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry Circulation 109 2004 190 195
46. F. Saia, P.A. Lemos, C.A. Arampatzis Routine sirolimus eluting stent implantation for unselected in-stent restenosis insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry Heart 90 2004 1183 1188
47. M. Valgimigli, C.A. van Mieghem, A.T. Ong Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH) Circulation 111 2005 1383 1389
48. F. Saia, P.A. Lemos, C.H. Lee Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction a clinical and angiographic study Circulation 108 2003 1927 1929
49. P. Urban, A.H. Gerschlick, G. Guagliumi The e-Cypher registry objectives and organization Ann Cardiol Angeiol (Paris) 53 Suppl 1 2004 18 21
50. D.O. Williams, D.J. Kereiakes Safety and efficacy of drug-eluting stents Rev Cardiovasc Med 6 Suppl 1 2005 22 30
51. C.A. Simonton, B.R. Brodie, B.H. Wilson Drug-eluting stents for emerging treatment strategies in complex lesions Rev Cardiovasc Med 6 Suppl 1 2005 38 47
52. A. Chieffo, A. Colombo Polymer-based paclitaxel-eluting coronary stents. Clinical results in de novo lesions Herz 29 2004 147 151
53. R. Zahn, C.W. Hamm, U. Zeymer "Real life" use of sirolimus-eluting coronary stents in Germany. Results from the prospective multi-centre German Cypher Registry Z Kardiol 93 2004 287 294
54. A. Wong, C. Chan Drug-eluting stents the end of restenosis? Ann Acad Med Singapore 33 2004 423 431
55. S.J. Hong, D.S. Lim, H.S. Seo Percutaneous coronary intervention with drug-eluting stent implantation versus minimally invasive direct coronary artery bypass (MIDCAB) in patients with left anterior descending coronary artery stenosis Catheter Cardiovasc Interv 64 2005 75 81
56. F. Saia, A. Marzocchi, P.W. Serruys Drug-eluting stents. The third revolution in percutaneous coronary intervention Ital Heart J 6 2005 289 303
57. Y. Honda, E. Grube, L.M. de La Fuente, P.G. Yock, S.H. Stertzer, P.J. Fitzgerald Novel drug-delivery stent intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system Circulation 104 2001 380 383
58. F. Liistro, G. Stankovic, C. Di Mario First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis immediate and long-term clinical and angiographic outcome Circulation 105 2002 1883 1886
59. R. Virmani, F. Liistro, G. Stankovic Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans Circulation 106 2002 2649 2651
60. P.A. Lemos, F. Saia, J.M. Ligthart Coronary restenosis after sirolimus-eluting stent implantation morphological description and mechanistic analysis from a consecutive series of cases Circulation 108 2003 257 260
61. King SB III. Restenosis: the mouse that roared. Circulation 200;108:248-9.
62. W.S. Weintraub, Z.M. Ghazzal, J.S. Douglas Jr Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty Circulation 87 1993 831 840
63. R. Virmani, A. Farb, F.D. Kolodgie Histopathologic alterations after endovascular radiation and antiproliferative stents similarities and differences Herz 27 2002 1 6
64. A. Babinska, M.S. Markell, M.O. Salifu, M. Akoad, Y.H. Ehrlich, E. Kornecki Enhancement of human platelet aggregation and secretion induced by rapamycin Nephrol Dial Transplant 13 1998 3153 3159
65. FDA public health web notification: updated information for physicians on sub-acute thromboses (SAT) and hypersensitivity reactions with use of the Cordis Cypher sirolimus-eluting coronary stent. Issued November 25, 2003. Available at: http://www.fda.gov/cdrh/safety/cypher2.html. Accessed June 2, 2005.
66. I. Iakovou, T. Schmidt, E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
67. A.A. Bavry, D.J. Kumbhani, T.J. Helton, D.L. Bhatt What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention? A meta-analysis J Am Coll Cardiol 45 2005 941 946
68. R. Moreno, C. Fernandez, R. Hernandez Drug-eluting stent thrombosis results from a pooled analysis including 10 randomized studies J Am Coll Cardiol 45 2005 954 959
69. M. Zimarino, G. Renda, R. De Caterina Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents Drugs 65 2005 725 732
70. F. Alfonso, A. Suarez, D.J. Angiolillo Findings of intravascular ultrasound during acute stent thrombosis Heart 90 2004 1455 1459
71. V. Bhatia, R. Bhatia, M. Dhindsa Drug-eluting stents new era and new concerns Postgrad Med J 80 2004 13 18
72. R. Virmani, A. Farb, G. Guagliumi, F.D. Kolodgie Drug-eluting stents caution and concerns for long-term outcome Cor Artery Dis 15 2004 313 318
73. K.M. Huh, S.C. Lee, Y.W. Cho, J. Lee, J.H. Jeong, K. Park Hydrotropic polymer micelle system for delivery of paclitaxel J Control Release 101 2005 59 68
74. R. Virmani, G. Guagliumi, A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent should we be cautious? Circulation 109 2004 701 705
75. O. Lev-Ran, R. Mohr, D. Pevni Bilateral internal thoracic artery grafting in diabetic patients short-term and long-term results of a 515-patient series J Thorac Cardiovasc Surg 127 2004 1145 1150
76. S.J. Shubrooks Jr, R.W. Nesto, D. Leeman Urgent coronary bypass surgery for failed percutaneous coronary intervention in the stent era is backup still necessary? Am Heart J 142 2001 190 196
77. S.G. Raja Clopidogrel before coronary artery surgery bleeding or no bleeding? Eur J Cardiothorac Surg 26 2004 231
78. L. Nalysnyk, K. Fahrbach, M.W. Reynolds, S.Z. Zhao, S. Ross Adverse events in coronary artery bypass graft (CABG) trials a systematic review and analysis Heart 89 2003 767 772
79. D.C. Cheng, D. Bainbridge, J.E. Martin, R.J. Novick Evidence-Based Perioperative Clinical Outcomes Research Group Does off-pump coronary artery bypass reduce mortality, morbidity, and resource utilization when compared with conventional coronary artery bypass? A meta-analysis of randomized trials Anesthesiology 102 2005 188 203
80. S.G. Raja, G.D. Dreyfus Off-pump coronary artery bypass surgery to do or not to do? Current best available evidence J Cardiothorac Vasc Anesth 18 2004 486 505
81. T.A. Vassiliades Jr, E.W. Rogers, J.L. Nielsen, J.L. Lonquist Minimally invasive direct coronary artery bypass grafting intermediate-term results Ann Thorac Surg 70 2000 1063 1065
82. S. Forlani, C. Bassano, F. Tomai Mid-term results of conventional bypass surgery for complex proximal left anterior descending coronary artery stenoses G Ital Cardiol 29 1999 781 786
83. R.H. Zeff, C. Kongtahworn, L.A. Iannone Internal mammary artery versus saphenous vein graft to the left anterior descending coronary artery prospective randomized study with 10-year follow-up Ann Thorac Surg 45 1988 533 536
84. A.M. Calafiore, G.D. Giammarco, G. Teodori Left anterior descending coronary artery grafting via left anterior small thoracotomy without cardiopulmonary bypass Ann Thorac Surg 61 1996 1658 1663
85. V. Gulielmos, M. Knaut, R. Cichon Experiences with a minimally invasive surgical technique for the treatment of coronary artery multivessel disease in 100 patients Eur J Cardiothorac Surg 14 1998 347 352
86. C. Detter, H. Reichenspurner, D.H. Boehm, M. Thalhammer, A. Schutz, B. Reichart Single vessel revascularization with beating heart techniques- minithoracotomy or sternotomy? Eur J Cardiothorac Surg 19 2001 464 470
87. V.A. Subramanian, J.C. McCabe, C.M. Geller Minimally invasive direct coronary artery bypass grafting two-year clinical experience Ann Thorac Surg 64 1997 1648 1653
88. A. Diegeler, V. Falk, M. Matin Minimally invasive coronary artery bypass grafting without cardiopulmonary bypass early experience and follow-up Ann Thorac Surg 66 1998 1022 1025
89. J.T. Cremer, T. Wittwer, A. Boning Minimally invasive coronary artery revascularization on the beating heart Ann Thorac Surg 69 2000 1787 1791
90. M.J. Mack, J.A. Magovern, T.A. Acuff Results of graft patency by immediate angiography in minimally invasive coronary artery surgery Ann Thorac Surg 68 1999 383 389
91. C. Briguori, T. Nishida, M. Adamian, C. Di Mario, J. Moses, A. Colombo Multivessel coronary stenting predictors of early and late outcome Ital Heart J 1 2000 420 425
92. J. Tatoulis, B.F. Buxton, J.A. Fuller Patencies of 2127 arterial to coronary conduits over 15 years Ann Thorac Surg 77 2004 93 101
93. S.G. Raja OPCAB and the incidence of atrial fibrillation ignoring the current best available evidence Eur J Cardiothorac Surg 27 2005 930